RADNOR, Pa.--(BUSINESS WIRE)--Kaskela Law LLC announces that it has commenced an investigation of MiMedx Group, Inc. (NASDAQ: MDXG) (“MiMedx” or the “Company”) on behalf of the Company’s stockholders.
MiMedx stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740 to discuss this investigation and their legal rights and options. Additional information about this investigation may also be found at www.kaskelalaw.com/case/mimedx.
On June 7, 2018, MiMedx disclosed that “the Audit Committee of the Company's Board of Directors, with concurrence from management of the Company, has concluded that the Company's previously issued consolidated financial statements relating to each of the fiscal years ended December 31, 2012, 2013, 2014, 2015, and 2016 and each of the interim periods ended March 31, June 30 and September 30, 2017 should be restated. As a result, all communications and financial information with respect to the fourth quarter of 2017 and the first quarter of 2018 should no longer be relied upon, and the Company is withdrawing all prior financial guidance issued for 2018.”
Following this news, shares of the Company’s common stock significantly declined on June 8, 2018.
MiMedx investors are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740, or via www.kaskelalaw.com/case/mimedx, to discuss their legal rights and options with respect to this investigation. Kaskela Law LLC exclusively prosecutes shareholder actions in state and federal courts throughout the country on behalf of investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.